Table S1 from Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis

Liang Liu,Lin Yang,Wei Yan,Jing Zhai,Donald P. Pizzo,Peiguo Chu,Andrew R. Chin,Meng Shen,Chuan Dong,Xianhui Ruan,Xiubao Ren,George Somlo,Shizhen Emily Wang

DOI: https://doi.org/10.1158/1078-0432.22464788.v1

2023-01-01

Abstract:Table S1 shows the clinical data of human specimens

What problem does this paper attempt to address?

Chemo-resistant Colorectal Cancer Cells Are Enriched for Tumor Stem Cells and Sensitive to IGF-1R Inhibition

Nikolaos A. Dallas,Ling Xia,Fan,Anthony D. Yang,Michael J. Gray,Shaija Samuel,Puja Gaur,Lee M. Ellis

DOI: https://doi.org/10.1016/j.jamcollsurg.2008.06.250

2008-01-01

Journal of the American College of Surgeons

Abstract:Dallas, Nikolaos A. MD; Xia, Ling MS; Fan, Fan BS; Yang, Anthony D. MD; Gray, Michael J. PhD; Samuel, Shaija PhD; Gaur, Puja MD; Ellis, Lee M. MD, FACS Author Information
Monitoring Cancer Stem Cells: Insights into Clinical Oncology.

ShuChen Lin,YingChun Xu,ZhiHua Gan,Kun Han,HaiYan Hu,Yang Yao,MingZhu Huang,DaLiu Min

DOI: https://doi.org/10.2147/ott.s96645

IF: 4

2016-01-01

OncoTargets and Therapy

Abstract:Cancer stem cells (CSCs) are a small, characteristically distinctive subset of tumor cells responsible for tumor initiation and progression. Several treatment modalities, such as surgery, glycolytic inhibition, driving CSC proliferation, immunotherapy, and hypofractionated radiotherapy, may have the potential to eradicate CSCs. We propose that monitoring CSCs is important in clinical oncology as CSC populations may reflect true treatment response and assist with managing treatment strategies, such as defining optimal chemotherapy cycles, permitting pretreatment cancer surveillance, conducting a comprehensive treatment plan, modifying radiation treatment, and deploying rechallenge chemotherapy. Then, we describe methods for monitoring CSCs.
Supplementary Table 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Jun-Ying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang-Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497775.v1

2023-01-01

Abstract:PDF file - 66K, Supplementary Table 1 Inductive Effect of BMS-777607 on Breast Cancer Polyploid Cells with Different Numbers of Chromosomes.
Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Sen Ye,Yan-Fu Ding,Wen-Huan Jia,Xiao-Li Liu,Jing-Yi Feng,Qian Zhu,Sun-Li Cai,Yao-Shun Yang,Qian-Yun Lu,Xue-Ting Huang,Jin-Shu Yang,Sheng-Nan Jia,Guo-Ping Ding,Yue-Hong Wang,Jiao-Jiao Zhou,Yi-Ding Chen,Wei-Jun Yang

DOI: https://doi.org/10.1158/0008-5472.22422729

2023-01-01

Abstract:Supplementary Table S1 and Supplementary Figure S1 to S11
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Table 2 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503681

2023-01-01

Abstract:PDF - 79K, Supplementary Table 2. Sensitivities of L3.6pl cells, CSCs+24/44/ESA and their derived polyploid cells in response to different chemotherapeutics.
Supplementary Table 1 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Lu Deng,Li Shang,Shoumin Bai,Ji Chen,Xueyan He,Rachel Martin-Trevino,Shanshan Chen,Xiao-yan Li,Xiaojie Meng,Bin Yu,Xiaolin Wang,Yajing Liu,Sean P. McDermott,Alexa E. Ariazi,Christophe Ginestier,Ingrid Ibarra,Jia Ke,Tahra Luther,Shawn G. Clouthier,Liang Xu,Ge Shan,Erwei Song,Herui Yao,Gregory J. Hannon,Stephen J. Weiss,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/0008-5472.22404494.v1

2023-01-01

Abstract:Subtypes of the 94 patients.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422961.v1

2024-01-01

Abstract:Participant characteristics of 80 patients with other cancers.
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419825.v1

2023-01-01

Abstract:Supplementary Table S3. Demographics of the included 332 osteosarcomas.
Supplementary Table 3 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503678.v1

2023-01-01

Abstract:PDF - 64K, Supplementary Table 3. Minimum Inhibitory Concentrations* of BMS-777607 and Chemoagents in L3.6pl Cells and L3.6pl Cell-Derived CSCs+24/44/ESA.
Supplementary Table S4 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Huanhuan Huang,Yao,Lesang Shen,Jingxin Jiang,Ting Zhang,Jia Xiong,Jiaxin Li,Shanshan Sun,Siwei Zheng,Fang Jia,Jun Zhou,Xiuyan Yu,Wuzhen Chen,Jun Shen,Wenjie Xia,Xuan Shao,Qingqing Wang,Jian Huang,Chao Ni

DOI: https://doi.org/10.1158/1078-0432.24826116

2023-01-01

Abstract:Table. S4. Characteristics of the patient samples and basic information.
Supplementary Table 1 from Mammary Epithelial-Specific Ablation of the Focal Adhesion Kinase Suppresses Mammary Tumorigenesis by Affecting Mammary Cancer Stem/Progenitor Cells

Ming Luo,Huaping Fan,Tamas Nagy,Huijun Wei,Chenran Wang,Suling Liu,Max S. Wicha,Jun-Lin Guan

DOI: https://doi.org/10.1158/0008-5472.22379081

2023-01-01

Abstract:Supplementary Table 1 from Mammary Epithelial-Specific Ablation of the Focal Adhesion Kinase Suppresses Mammary Tumorigenesis by Affecting Mammary Cancer Stem/Progenitor Cells
Table S6 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Jie Sun,Hua Meng,Lu Yao,Meng Lv,Jian Bai,Jianguang Zhang,Lientu Wang,Tao Ouyang,Jinfeng Li,Tianfeng Wang,Zhaoqing Fan,Tie Fan,Benyao Lin,Yuntao Xie

DOI: https://doi.org/10.1158/1078-0432.22463217.v1

2023-01-01

Abstract:Univariate Analyses of Disease-free Survival and Disease-specific Survival
Table S1 from Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

Guoliang Qiao,Xiaoli Wang,Lei Zhou,Xinna Zhou,Yuguang Song,Shuo Wang,Lei Zhao,Michael A. Morse,Amy Hobeika,Jin Song,Xin Yi,Xuefeng Xia,Jun Ren,Herbert Kim Lyerly

DOI: https://doi.org/10.1158/1078-0432.22472409

2023-01-01

Abstract:<p>Supplementary table 1: Cox proportional hazard regression analysis of patients' demographic and clinical characteristics related with overall survival.</p>
Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Tianyuan Liu,Xuan Zhao,Yuan Lin,Qi Luo,Shaosen Zhang,Yiyi Xi,Yamei Chen,Lin,Wenyi Fan,Jie Yang,Yuling Ma,Alok K. Maity,Yanyi Huang,Jianbin Wang,Jiang Chang,Dongxin Lin,Andrew E. Teschendorff,Chen Wu

DOI: https://doi.org/10.1158/0008-5472.22431860.v1

2023-01-01

Abstract:Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression
Supplementary Table S2 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Huanhuan Huang,Yao,Lesang Shen,Jingxin Jiang,Ting Zhang,Jia Xiong,Jiaxin Li,Shanshan Sun,Siwei Zheng,Fang Jia,Jun Zhou,Xiuyan Yu,Wuzhen Chen,Jun Shen,Wenjie Xia,Xuan Shao,Qingqing Wang,Jian Huang,Chao Ni

DOI: https://doi.org/10.1158/1078-0432.24826125.v1

2023-01-01

Abstract:Table. S2. Annotation of the 92 Olink biomarkers studied herein.
Supplementary Figures 15 from Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks

Suling Liu,Christophe Ginestier,Sing J. Ou,Shawn G. Clouthier,Shivani H. Patel,Florence Monville,Hasan Korkaya,Amber Heath,Julie Dutcher,Celina G. Kleer,Younghun Jung,Gabriela Dontu,Russell Taichman,Max S. Wicha

DOI: https://doi.org/10.1158/0008-5472.22386182

2023-01-01

Abstract:Supplementary Figures 15 from Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures

Fei Ji,Jiao-Mei Yuan,Hong-Fei Gao,Ai-Qi Xu,Zheng Yang,Ci-Qiu Yang,Liu-Lu Zhang,Mei Yang,Jie-Qing Li,Teng Zhu,Min-Yi Cheng,Si-Yan Wu,Kun Wang

DOI: https://doi.org/10.3389/fmolb.2021.759495

IF: 6.113

2021-10-11

Frontiers in Molecular Biosciences

Abstract:Immune response which involves distinct immune cells is associated with prognosis of breast cancer. Nonetheless, less study have determined the associations of different types of immune cells with patient survival and treatment response. In this study, A total of 1,502 estrogen receptor(ER)-negative breast cancers from public databases were used to infer the proportions of 22 subsets of immune cells. Another 320 ER-negative breast cancer patients from Guangdong Provincial People’s Hospital were also included and divided into the testing and validation cohorts. CD8 + T cells, CD4 + T cells, B cells, and M1 macrophages were associated with favourable outcome (all p <0.01), whereas Treg cells were strongly associated with poor outcome ( p = 0.005). Using the LASSO model, we classified patients into the stromal immunotype A and B subgroups according to immunoscores. The 10 years OS and DFS rates were significantly higher in the immunotype A subgroup than immunotype B subgroup. Stromal immunotype was identified as an independent prognostic indicator in multivariate analysis in all cohorts and was also related to pathological complete response(pCR) after neoadjuvant chemotherapy. The nomogram that integrated the immunotype and clinicopathologic features showed good predictive accuracy for pCR and discriminatory power. The stromal immunotype A subgroup had higher expression levels of immune checkpoint molecules (PD-L1, PD-1, and CTLA-4) and cytokines (IL-2, INF-γ, and TGF-β). In addition, patients with immunotype A and B diseases had distinct mutation signatures. Therefore, The stromal immunotypes could predict survival and responses of ER-negative breast cancer patients to neoadjuvant chemotherapy.

biochemistry & molecular biology
Supplementary Table 2 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Lu Deng,Li Shang,Shoumin Bai,Ji Chen,Xueyan He,Rachel Martin-Trevino,Shanshan Chen,Xiao-yan Li,Xiaojie Meng,Bin Yu,Xiaolin Wang,Yajing Liu,Sean P. McDermott,Alexa E. Ariazi,Christophe Ginestier,Ingrid Ibarra,Jia Ke,Tahra Luther,Shawn G. Clouthier,Liang Xu,Ge Shan,Erwei Song,Herui Yao,Gregory J. Hannon,Stephen J. Weiss,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/0008-5472.22404491.v1

2023-01-01

Abstract:<p>Clinical stages and the percentage of ALDH1+ cells and mir-100+ cells of the 94 patients.</p>

Table S1 from Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis

Chemo-resistant Colorectal Cancer Cells Are Enriched for Tumor Stem Cells and Sensitive to IGF-1R Inhibition

Monitoring Cancer Stem Cells: Insights into Clinical Oncology.

Supplementary Table 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Table 2 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Table 1 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 3 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Table S4 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Supplementary Table 1 from Mammary Epithelial-Specific Ablation of the Focal Adhesion Kinase Suppresses Mammary Tumorigenesis by Affecting Mammary Cancer Stem/Progenitor Cells

Table S6 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Table S1 from Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Supplementary Table S2 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Supplementary Figures 15 from Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures

Supplementary Table 2 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development